Last Round
Series A
Mar 26, 2026
Est. Valuation
$2B
Total Funding Raised
$200M
Momentum Score
25 /100
Company Overview
eMed is a healthtech company that provides a digital health platform offering telehealth services, at-home diagnostics, and clinically managed GLP-1 weight management programs.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical AI, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eMed Comps
Public and private peers based on sector, stage, and business model.
eMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 26, 2026 |
eMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Knighthead Capital Management | Series A |
| Paragon Biosciences | Series A |
| 8VC | Series A |
| Valor Equity Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
$200M Series A round completed.
eMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about eMed's valuation, stock price, and market status.
